Mammographic surveillance in women aged 35–39 at enhanced familial risk of breast cancer (FH02)

Although there have been encouraging recent studies showing a potential benefit from annual mammography in women aged 40–49 years of age with an elevated breast cancer risk due to family history there is little evidence of efficacy in women aged